Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients

NCT07709637 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
COVID-19 (SARS-CoV-2 Infection)

Interventions

BIOLOGICAL: LB-DTK-COV19

Sponsor

LucasBio